BP000093-CYT-149: Recombinant Human 4-1BB Ligand
Source: E. coli-derived.
Fully biologically active when compared to standard. Determined by the dose-dependent stimulation of IL-8 production by human PBMC. The ED50 for this effect is 5-10ug/ml corresponding to a Specific Activity of 100,000-200,000 IU/mg.
Purity > 95%, by SDS-PAGE.BP001328-PRO-371: Myelin oligodendrocyte glycoprotein (MOG) Peptide (35-55)
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP000461-VZV-233: Recombinant Varicella Zoster Virus ORF26
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WBs, ELISA.BP000975-ENZ-340: Recombinant Human Ubiquitin Conjugating Enzyme E2B (UBE2B)
Source: E. coli-derived.
Purity: > 95% by RP-HPLC and SDS-PAGE.BP000459-TOX-263: Recombinant Toxoplasma Gondii p29 (GRA7)
Source: E. coli-derived.
Specificity: Immunoreactive with sera of Toxoplasma gondii-infected individuals.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.BP000123-CYT-393: Recombinant Rat Tumor Necrosis Factor-α (TNFα) Protein
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is < 0.05 ng/ml, corresponding to a Specific Activity of 20 MIU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000503-PRO-339: Human Thrombin Protein
Source: Human Plasma-derived.
The specific activity of Human Thrombin Protein was found to be 3003 NIH Units/mg.BP000730-ENZ-303: Recombinant Human Tissue Transglutaminase, Sf9
Source: Sf9 insect cells-derived.
A glycosylated, polypeptide chain having a molecular mass of 78,018 Dalton.
Purity > 95%, by SDS-PAGE.
Applications: WB.BP000458-SARS-250: Recombinant SARS-CoV Nucleocapsid (422a.a)
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.
Applications: WB.BP000457-RUB-291: Recombinant Rubella Virus E1 Mosaic
Source: E. coli-derived.
Specificty: Immunoreactive with sera of Rubella Virus infected individuals.
Purity > 95%, by 10% HPLC and SDS-PAGE.
Applications: WB, ELISA.